In The News - Infectious Disease
WCVB News 5 Boston | October 09, 2020
Ted Wayman reports on the recent $20 million contract awarded to Quanterix by the National Institutes of Health to see if their blood test for COVID-19 is more accurate than the current nasal swab test.
featuring Kevin Hrusovsky | May 12, 2020
The Passionate Pioneers Podcast covers conversations with the innovators, the game changers, and the PIONEERS who are deeply passionate and relentless in solving the problems that our world is facing!
Ultra-sensitive Simoa technology powers a new COVID-19 antibody test that can detect antibodies at 1000x lower concentrations
WCVB News 5 | May 12, 2020
Ultra-sensitive Simoa technology powers a new COVID-19 antibody test that can detect antibodies at 1000x lower concentrations. Quanterix CEO Kevin Hrusovsky and Dr.
SelectScience Interview | January 29, 2018
Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease
February 20, 2015
GenomeWeb Read the article at www.genomeweb.com
September 15, 2015
GenomeWeb Read the article at www.genomeweb.com.